Chronic lymphocytic leukaemia (CLL) is a progressive, malignant disease of the blood-forming organs, marked by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Latest Research and Reviews ATM aberrations in chronic lymphocytic leukemia: del(11q)...
Comments & OpinionOpen Access25 Mar 2025International Journal of Impotence Research P: 1-2 Turning down the heat in NEPC Louise Lloyd Research Highlights16 Jan 2025Nature Reviews Urology Volume: 22, P: 71 Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients ...
Plan individualized treatment approaches for relapsed/refractory CLL/SLL, based on optimal sequencing strategies recommended in the NCCN Guidelines (e.g. assessment of response/intolerance to first-line therapy, testing for resistant mutations, and patient eligibility for therapy) Evaluate emerging data fo...
EP: 2.Clinical Implications and Unmet Needs in CLL BTKi Therapies EP: 3.Navigating New BTKi Treatment Strategies in Mantle Cell Lymphoma EP: 4.Integrating Emerging BTKi Therapies Into Current Treatment Guidelines EP: 5.Future Directions and Research Priorities in BTKi Treatment Approaches Now Viewi...
Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment Fast Five QuizApril 24, 2025 Unprecedented Case of Rhabdomyoma in a Young Boy Clinical CaseApril 24, 2025 Fast Five Quiz: Early-Stage Breast Cancer Fast Five QuizApril 24, 2025 ...
Fast Five Quiz: Chronic Lymphocytic Leukemia (CLL) Treatment Fast Five QuizApril 24, 2025 Unprecedented Case of Rhabdomyoma in a Young Boy Clinical CaseApril 24, 2025 Fast Five Quiz: Early-Stage Breast Cancer Fast Five QuizApril 24, 2025 ...
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Expanded Indications for Hodgkin and CLL Drugs in Europe Medscape Medical NewsMay 1, 2025 Secondary Cancer Risk Rises After Cutaneous B-Cell Lymphoma Medscape Medical NewsMay 1, 2025 California’s Primary Care Shortage Persists KFF Health News44 minutes ago ...
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
The research is now undergoing a second phase of clinical testing in which CLL patients will each receive 2,000 milligrams of Polyphenon E twice daily. Insulin resistence/intolerance found to increase cancer risk A while ago, at CANCERactive we told you all about Insulin Resistance. ’Do you ...